🇺🇸 FDA
Patent

US 7166721

Preparation of 1H-imidazo[4,5-C] quinolin 4-amines via novel 1H-imidazo[4,5-c] quinolin 4-cyano and 1H-imidazo[4,5-c] quinolin 4-carboxamide intermediates

granted A61PA61P31/12A61P37/02

Quick answer

US patent 7166721 (Preparation of 1H-imidazo[4,5-C] quinolin 4-amines via novel 1H-imidazo[4,5-c] quinolin 4-cyano and 1H-imidazo[4,5-c] quinolin 4-carboxamide intermediates) held by TEVA Gyógyszergyár Zártkörüen Müködö Részvénytárasaság expires Mon Jan 18 2027 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
TEVA Gyógyszergyár Zártkörüen Müködö Részvénytárasaság
Grant date
Tue Jan 23 2007 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 18 2027 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
14
CPC classes
A61P, A61P31/12, A61P37/02